Grover Steven P, Saha Prakash, Jenkins Julia, Mukkavilli Arun, Lyons Oliver T, Patel Ashish S, Sunassee Kavitha, Modarai Bijan, Smith Alberto
Academic Department of Vascular Surgery, Cardiovascular Division, King's College London, BHF Centre of Research Excellence & NIHR Biomedical Research Centre at King's Health Partners, St Thomas' Hospital, London, UK.
Division of Imaging Sciences and Biomedical Engineering, King's College London, Wellcome Trust - EPSRC Medical Engineering Centre & NIHR Biomedical Research Centre at King's Health Partners, St. Thomas' Hospital, London, UK.
Thromb Res. 2015 Dec;136(6):1285-90. doi: 10.1016/j.thromres.2015.10.006. Epub 2015 Oct 9.
The assessment of thrombus size following treatments directed at preventing thrombosis or enhancing its resolution has generally relied on physical or histological methods. This cross-sectional design imposes the need for increased numbers of animals for experiments. Micro-computed tomography (microCT) has been used to detect the presence of venous thrombus in experimental models but has yet to be used in a quantitative manner. In this study, we investigate the use of contrast-enhanced microCT for the longitudinal assessment of experimental venous thrombus resolution.
Thrombi induced by stenosis of the inferior vena cava in mice were imaged by contrast-enhanced microCT at 1, 7 and 14 days post-induction (n=18). Thrombus volumes were determined longitudinally by segmentation and 3D volume reconstruction of microCT scans and by standard end-point histological analysis at day 14. An additional group of thrombi were analysed solely by histology at 1, 7 and 14 days post-induction (n=15).
IVC resident thrombus was readily detectable by contrast-enhanced microCT. MicroCT-derived measurements of thrombus volume correlated well with time-matched histological analyses (ICC=0.75, P<0.01). Thrombus volumes measured by microCT were significantly greater than those derived from histological analysis (P<0.001). Intra- and inter-observer analyses were highly correlated (ICC=0.99 and 0.91 respectively, P<0.0001). Further histological analysis revealed noticeable levels of contrast agent extravasation into the thrombus that was associated with the presence of neovascular channels, macrophages and intracellular iron deposits.
Contrast-enhanced microCT represents a reliable and reproducible method for the longitudinal assessment of venous thrombus resolution providing powerful paired data.
针对预防血栓形成或促进其溶解的治疗后,血栓大小的评估通常依赖于物理或组织学方法。这种横断面设计需要增加实验动物的数量。微计算机断层扫描(microCT)已被用于检测实验模型中静脉血栓的存在,但尚未用于定量分析。在本研究中,我们探讨了对比增强微CT在实验性静脉血栓溶解纵向评估中的应用。
通过下腔静脉狭窄诱导小鼠形成血栓,并在诱导后第1、7和14天用对比增强微CT成像(n = 18)。通过微CT扫描的分割和三维体积重建以及在第14天进行的标准终点组织学分析纵向确定血栓体积。另一组血栓仅在诱导后第1、7和14天通过组织学分析(n = 15)。
对比增强微CT很容易检测到下腔静脉内的血栓。微CT得出的血栓体积测量值与时间匹配的组织学分析相关性良好(ICC = 0.75,P < 0.01)。微CT测量的血栓体积明显大于组织学分析得出的体积(P < 0.001)。观察者内和观察者间分析高度相关(ICC分别为0.99和0.91,P < 0.0001)。进一步的组织学分析显示,有明显水平的造影剂渗入血栓,这与新生血管通道、巨噬细胞和细胞内铁沉积的存在有关。
对比增强微CT是一种可靠且可重复的方法,用于静脉血栓溶解的纵向评估,可提供有力的配对数据。